<html><body><h2>Case: 184216</h2><h3> CDS Time: 1933-06-17</h3>
<patient name=184216>
33.0 year old Black_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">33</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">60</td><td width="200">1933-1-9</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">60</td><td width="200">1933-1-9</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">91</td><td width="200">1933-5-2</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">66</td><td width="200">1933-5-5</td></tr>
<tr><td width="200">Chloride</td><td width="200">98.0</td><td width="200">1933-5-8</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">31</td><td width="200">1933-5-5</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">71</td><td width="200">1933-5-26</td></tr>
<tr><td width="200">B 12</td><td width="200">723.0</td><td width="200">1932-5-17</td></tr>
<tr><td width="200">Weight</td><td width="200">171</td><td width="200">1933-5-1</td></tr>
<tr><td width="200">HbA1C</td><td width="200">5</td><td width="200">1933-5-3</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">95</td><td width="200">1933-5-5</td></tr>
<tr><td width="200">Urine_ALB/CREAT_RATIO_spot</td><td width="200">1,291</td><td width="200">1933-3-13</td></tr>
<tr><td width="200">Urine_Alb/creat_Ratio_24h</td><td width="200">1,291</td><td width="200">1933-3-13</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">118</td><td width="200">1933-5-5</td></tr>
<tr><td width="200">SGOT</td><td width="200">11</td><td width="200">1933-5-2</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">125</td><td width="200">1933-5-26</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1933-5-2</td></tr>
<tr><td width="200">Height</td><td width="200">66</td><td width="200">1933-5-1</td></tr>
<tr><td width="200">Potassium</td><td width="200">5</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">118</td><td width="200">1933-5-5</td></tr>
<tr><td width="200">BUN</td><td width="200">68</td><td width="200">1933-5-26</td></tr>
<tr><td width="200">HCT</td><td width="200">30</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">HGB</td><td width="200">10</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">Sodium</td><td width="200">134</td><td width="200">1933-5-8</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1933-5-2</td></tr>
<tr><td width="200">Creatinine</td><td width="200">14.0</td><td width="200">1933-5-8</td></tr>
<tr><td width="200">UrineAlbumin_24H</td><td width="200">1,930</td><td width="200">1933-3-13</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">5</td><td width="200">1933-5-3</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">60.0</td><td width="200">1933-1-9</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">60</td><td width="200">1933-1-9</td></tr>
<tr><td width="200">UrineAlbumin_SPOT</td><td width="200">1,930</td><td width="200">1933-3-13</td></tr>
<tr><td width="200">Pulse</td><td width="200">87</td><td width="200">1933-5-26</td></tr>
<tr><td width="200">PLT</td><td width="200">182</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">WBC</td><td width="200">6</td><td width="200">1933-5-21</td></tr>
<tr><td width="200">SGPT</td><td width="200">21</td><td width="200">1933-5-2</td></tr>
<tr><td width="200">Hepatitis_C_Status</td><td width="200">Negative</td><td width="200">1930-12-9</td></tr>
<tr><td width="200">Hepatitis_B_Surface_Antigen</td><td width="200">Negative</td><td width="200">1930-12-9</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">Black_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Volume overload</td><td width="200"></td><td width="200">1933-5-21</td></tr>
<tr><td width="200">Depression</td><td width="200"></td><td width="200">1933-3-6</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1933-5-8</td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1933-5-4</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1933-5-8</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1933-5-8</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1933-5-8</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1933-5-21</td></tr>
<tr><td width="200">fluid retention</td><td width="200"></td><td width="200">1933-5-21</td></tr>
<tr><td width="200">Renovascular_Disease</td><td width="200"></td><td width="200">1933-5-21</td></tr>
</table>
<p><b>Medications:</b> labetalol(400.0) lisinopril(40.0) hydrochlorothiazide(0.0) hydralazine(20.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(134.0/1933-5-8)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(14.0/1933-5-8)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[HDL_Cholesterol(31.0/1933-5-5)]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(71/null) && Treatment_Systolic_BP(125/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(71/null) && Treatment_Systolic_BP(125/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[HDL_Cholesterol(31.0/1933-5-5)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[presence of CKD (icd9 codes)]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Male and most recent creatinine>2.5</td>
<td width="200"></td>
<td width="200"> Male and most recent creatinine>2.5[Sex(Male) && Creatinine(14.0/1933-5-8)]()</td></tr>
<tr><td width="200">Most recent K>=5</td>
<td width="200"></td>
<td width="200"> Most recent K>=5[Potassium(5.2/1933-5-21)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1933-05-21</td>
<td width="200"> Renovascular_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200">1933-05-08</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1933-05-08</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1933-05-08</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1933-05-04</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1933-05-08</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1933-03-06</td>
<td width="200"> Depression()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1930-12-09</td>
<td width="200"> Hepatitis_C_Status()
<tr> <td width="200"></td>
<td width="200">1933-05-21</td>
<td width="200"> fluid retention()
<tr> <td width="200"></td>
<td width="200">1930-12-09</td>
<td width="200"> Hepatitis_B_Surface_Antigen()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1933-05-21</td>
<td width="200"> Volume overload()
<tr> <td width="200"></td>
<td width="200">1933-05-21</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(66.0/1933-5-5))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(71/null) && Treatment_Systolic_BP(125/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>aldosterone antagonist<ul><li>Contraindications:  Male and most recent creatinine>2.5(Male and most recent creatinine>2.5[Sex(Male) && Creatinine(14.0/1933-5-8)])  Most recent K>=5(Most recent K>=5[Potassium(5.2/1933-5-21)]) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>ARB<ul><li>preference: neutral<li>No comment</ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomyopathy) <li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>